High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals

Microbial Drug Resistance

Volumn 18, Issue 4, 2012, Pages 390-395

  Markovska, Rumyana ^a   Schneider, Ines ^b   Ivanova, Dobrinka ^c   Keuleyan, Emma ^d   Stoeva, Temenuga ^e   Sredkova, Mariya ^f   Markova, Boyka ^g   Bojkova, Kalina ^e   Gergova, Raina ^a   Bauernfeind, Adolf ^b   Mitov, Ivan ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b MICOER Institute   (Germany)

^c Second Multiprofile Hospital   (Bulgaria)

^d Ministry of Interior   (Bulgaria)

^e VARNA UNIVERSITY OF MANAGEMENT   (Bulgaria)

^f MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

^g UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BULGARIA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EUROPE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HOSPITAL; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BULGARIA; CARBAPENEMS; CLONE CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; ISOELECTRIC FOCUSING; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; POPULATION SURVEILLANCE; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

ESCHERICHIA COLI;

EID: 84864359518     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0186     Document Type: Article

References (30)

1. Bauernfeind,A., I. Schneider, R. Jungwirth,H. Sahly, and U. Ullmann. 1999. A novel type of AmpC Beta-Lactamase, ACC- 1, produced by a Klebsiella pneumoniae causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43:1924-1931.
2. Blanco, M., M. Alonso, M. Nicolas-Chanoine, G. Dahbi, A. Mora, J. Blanco, C. Ló pez, P. Cortes, M. Llagostera, V. Leflon-Guibout, et al. 2009. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases in Lugo (Spain): Dissemination of clone O25b:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 63:1135-1141.
3. Bonnet, R. 2004. Growing group of extended-spectrum betalactamases: The CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
4. Bradford, P.A. 2001. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
5. Coelho, A., A. Mora, R. Mamani, C. Ló pez, J. González- Ló pez, M. Larrosa, J. Quintero-Zarate, G. Dahbi, A. Herrera, J. Blanco, M. Blanco, et al. 2011. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J. Antimicrob. Chemother. 66:517-526.
6. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple detection of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
7. Clermont, O., H. Dhanji, M. Upton, T. Gibreel, A. Fox, D. Boyd, M. Mulvey, P. Nordmann, E. Ruppé , J. Sarthou, T. Frank, S. Vimont, G. Arlet, C. Branger, N. Woodford, and E. Denamur. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
8. Clinical and Laboratory Standards Institute. 2010. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth Informational Supplement. Approve standard M100-S20. CLSI, Wayne, PA.
9. Coque, T. 2008. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance 47:1-11.
10. Coque, T., A. Novais, A. Carattoli, L. Poirel, J. Pitout, L. Peixe, F. Baquero, R. Cantó n, and P. Nordmann. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
11. Jarlier, V., M. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum b-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
12. Johnson, J., B. Johnston, C. Clabots, M. Kuskowski, and M. Castanheira. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
13. Karim, A., L. Poirel, S. Nagarajan, and P. Nordmann. 2001. Plasmid-mediated extended-spectrum b-lactamases (CTXM- 3 like) from India and association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201:237-241.
14. Lau, S., M. Kaufmann, D. Livermore, N. Woodford, G. Willshaw, T. Cheasty, K. Stamper, S. Reddy, J. Cheesbrough, F. Bolton, A. Fox, and M. Upton. 2008. Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25 K:H4-ST131 clone. J. Antimicrob. Chemother. 62:1241-1244.
15. Livermore, D., R. Canton, M. Gniadkowski, P. Nordmann, G. Rossolini, G. Arlet, J. Ayala, T. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, and N. Woodford. 2007. CTX-M: Changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.
16. Markovska, R., I. Schneider, E. Keuleyan, and A. Bauernfeind. 2004. Extended spectrum beta-lactamase (ESBL) CTXM-producing E. coli and K. pneumoniae in Sofia, Bulgaria. Clin. Microbiol. Infect. 8:752-755.
17. Markovska, R., I. Schneider, E. Keuleyan, M. Sredkova, D. Ivanova, B. Markova, G. Lazarova, E. Dragijeva, E. Savov, I. Haydouchka, N. Hadjieva, L. Setchanova, I. Mitov, and A. Bauernfeind. 2008. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae in Bulgarian hospitals. Microb. Drug Resist. 14:119-128.
18. Matthew, M., A. Harris, M. Marshall, and G. Ross. 1975. The use of analytical isoelectric focussing for detection and identification of beta-lactamases. J. Gen. Microbiol. 88:169-178.
19. Mora, A., M. Blanco, C. Ló pez, R. Mamani, J. Blanco, M. Alonso, F. García-Garrote, G. Dahbi, A. Herrera, A. Fernández, B. Fernández, A. Agulla, G. Bou, and J. Blanco. 2011. Emergence of clonal groups O1:HNM-D-ST59, O15:H1- D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int. J. Antimicrob. Agents 37:16-21.
20. Nicolas-Chanoine, M., J. Blanco, V. Leflon-Guibout, R. Demarty, M. Alonso, M. Caniça, Y. Park, J. Lavigne, J. Pitout, and J. Johnson. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
21. Peirano, G., and J. Pitout. 2010. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: The worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316-321.
22. Peirano, G., C. van Greune, and J. Pitout. 2011. Characteristics of infections caused by extended-spectrum b-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagn. Microbiol. Infect.Dis. 69:449-453.
23. Pitout, J. 2010. Infections with extended-spectrum betalactamase- producing enterobacteriaceae: Changing epidemiology and drug treatment choices. Drugs 70:313-333.
24. Pitout, J., D. Gregson, L. Campbell, and K. Laupland. 2009. Molecular characteristics of extended-spectrum-beta-lactamaseproducing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents Chemother. 53:2846-2851.
25. Rogers, B., H. Sidjabat, and D. Paterson. 2011. Escherichia coli O25b-ST131: A pandemic, multiresistant, communityassociated strain. J. Antimicrob. Chemother. 66:1-14.
26. Ruiz, S., M. Montealegre, P. Ruiz-Garbajosa, A. Correa, D. Briceñ o, E. Martinez, and M. Villegas. 2011. First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J. Clin. Microbiol. 49:1993-1996.
27. Simner, P., G. Zhanel, J. Pitout, F. Tailor, M. McCracken, and M. Mulvey; Canadian Antimicrobial Resistance Alliance (CARA). 2011. Prevalence and characterization of extended-spectrum beta-lactamase- and AmpC b- actamaseproducing Escherichia coli: Results of the CANWARD 2007- 2009 study. Diagn. Microbiol. Infect. Dis 69:326-334.
28. Uchida, Y., T. Mochimaru, Y. Morokuma, M. Kiyosuke, M. Fujise, F. Eto, Y. Eriguchi, Y. Nagasaki, N. Shimono, and D. Kang. 2010. Clonal spread in Eastern Asia of ciprofloxacinresistant Escherichia coli serogroup O25 strains, and associated virulence factors. Int. J. Antimicrob. Agents 35:444-450.
29. Versalovic, J., T. Koeuth, and J. Lupski. 1991. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19:6823-6831.
30. Yumuk, Z., G. Afacan, M. Nicolas-Chanoine, A. Sotto, and J. Lavigne. 2008. Turkey: A further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 62:284-288.